Summary

Overview
Global Laboratory Proficiency Testing Market reached US$ XX million in 2023 and is expected to reach US$ XX million by 2031, growing at a CAGR of XX% during the forecast period 2024-2031.
Laboratory proficiency testing is an external quality and accuracy assessment process that tests unknown specimens from an outside source to ensure accurate lab testing results. Lab proficiency testing is more than an internal quality control measure. It provides an important comparison and objective assessment of your lab staff competencies, specimen handling, equipment functionality, and results reporting.
Market Dynamics: Drivers & Restraints
Increasing adoption of proficiency testing services
The laboratory proficiency testing market is experiencing growth due to the increasing adoption of proficiency testing services. These services enable laboratories to evaluate and monitor the quality and accuracy of their testing processes, meeting quality standards and regulatory requirements. The increasing number of accredited laboratories and the need for ISO certifications further boost the adoption of these services. Additionally, these services are being used to train staff, identify gaps, implement corrective measures, and improve patient safety. The growing reliance on accurate test results and focus on quality patient care are key factors driving this adoption.

High investments

The high investment in inaccurate and minute testing is a major restraint for the global laboratory proficiency testing market. Testing is done using sophisticated and expensive instruments such as a spectrophotometer, HPLC, Gel Permeation Chromatography Systems, Cell Harvest Systems, and many more.
It also costs a great deal to install these instruments; as a result, laboratory proficiency testing requires a heavy investment. Further, costly methods such as ELISA and PCR are employed in the global laboratory proficiency testing market, which requires highly skilled technicians and increases the cost of laboratory proficiency training, thereby hampering the market growth.
For more details on this report – Request for Sample
Segment Analysis
The global laboratory proficiency testing market is segmented based on industry type, technology, end-user and region.
The clinical diagnostics from the industry type segment accounted for approximately 37.3% of the laboratory proficiency testing market share
The clinical diagnostics from the industry type segment accounted for approximately 37.3%. Clinical diagnostic laboratories have shown lower diagnostic error rates compared to hospitals, leading to the widespread adoption of Prototype Generation (PT) for accurate results and effective quality management.
The development of complex diagnostic tests and high early diagnosis rates necessitate the importance of quality management with proficiency testing in clinical diagnostics. Proficiency testing enhances efficiency, reproducibility, and accuracy of testing.
For instance, in October 2023, a recent reanalysis of a pilot study published, the Archives of Pathology & Laboratory Medicine reveals that molecular testing laboratories using College of American Pathologists proficiency testing (PT) programs demonstrate excellent testing performance. The study indicates that patients undergoing molecular testing at these laboratories can still trust the accuracy of their test results, demonstrating the high-quality data across the over 23,000 participating laboratories.
Geographical Analysis
North America is estimated to hold about 38.4% of the total market share throughout the forecast period
North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to factors like adoption of proficiency testing to demonstrate operational excellence, increasing regulatory stringency regarding laboratory operations, and the presence of a large number of global proficiency testing providers in North America. Also, North America is a major hub for industries such as pharmaceuticals, food, water & environment, commercial beverages, cosmetics, and cannabis testing.
For instance, in March 2023, The College of American Pathologists, has introduced a new monkeypox (mpox) virus proficiency testing (PT) program for laboratories within the United States that will ship to customers in early summer.
By Industry Type
• Clinical Diagnostics
o Immunochemistry
o Clinical Chemistry
o Cytology Testing
o Genetic Testing
o Others
• Pharmaceuticals
o Branded/Innovator Drugs
o Generics
o Biosimilars
• Biologics
o Blood
o Vaccines
o Tissue Related
• Microbiology
o Sterility Testing
o Endotoxin & Pyrogen Testing
o Pathogen Testing
o Growth Promotion Testing
o Others
• Others
By Technology
• Immunoassay
• Spectrometry
• Polymerase Chain Reaction
• Chromatography
• Others
By End User
• Hospitals
• Diagnostic Centers
• Pharmaceutical and Biotechnology Companies
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include LGC Limited, Bio-Rad Laboratories, Merck KGaA, College of American Pathologists, Waters Corporation, FAPAS, Phenova lnc, Weqas, Advanced Analytical Solutions, LLC, and Trilogy Analytical Laboratory among others.
Key Developments
 In April 2023, BIPEA unveiled PTS 110A, a new Proficiency Testing Scheme that enables testing laboratories to assess their analytical capabilities by analyzing a rice sample. This initiative can empower laboratories to evaluate and enhance their performance in rice sample analysis, driving excellence in the field.
 In January 2023, BIPEA introduced a novel proficiency test in surface microbiology, expanding its range of offerings. This new test allows professionals in the field to enhance their expertise and proficiency in surface microbiology analysis.

Why Purchase the Report?
• To visualize the global laboratory proficiency testing market segmentation based on industry type, technology, end user, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the laboratory proficiency testing market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.
The global laboratory proficiency testing market report would provide approximately 64 tables, 61 figures, and 186 pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents

Table of Contents
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Industry Type
3.2. Snippet by Technology
3.3. Snippet by End User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing adoption of proficiency testing services
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. High investments
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
5.6. PESTLE Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. By Industry Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Industry Type
6.1.2. Market Attractiveness Index, By Industry Type
6.2. Clinical Diagnostics*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Pharmaceuticals
6.4. Biologics
6.5. Microbiology
6.6. Others
7. By Technology
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
7.1.2. Market Attractiveness Index, By Technology
7.2. Immunoassay*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Spectrometry
7.4. Polymerase Chain Reaction
7.5. Chromatography
7.6. Others
8. By End User
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Diagnostic Centers
8.4. Pharmaceutical and Biotechnology Companies
8.5. Others
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Industry Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Industry Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. UK
9.3.6.3. France
9.3.6.4. Italy
9.3.6.5. Spain
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Industry Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Industry Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. South Korea
9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Industry Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. LGC Limited*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. Bio-Rad Laboratories
11.3. Merck KGaA
11.4. College of American Pathologists
11.5. Waters Corporation
11.6. FAPAS
11.7. Phenova lnc
11.8. Weqas
11.9. Advanced Analytical Solutions, LLC
11.10. Trilogy Analytical Laboratory
LIST NOT EXHAUSTIVE
12. Appendix
12.1. About Us and Services
12.2. Contact Us